The original guidelines, which this document supersedes, were written in 2000 and have undergone extensive revision by members of the Guidelines Development Group (GDG).
The GDG comprizes representatives from patient/carer groups, elected members of the BSG liver section, British Association for the Study of the Liver (BASL), Specialist Advisory Committee in Clinical Biochemistry/Royal College of Pathology and Association for Clinical Biochemistry, British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN), Public Health England, Royal College of General Practice, British Society of Gastrointestinal and Abdominal Radiologists (BSGAR) and Society of Acute Medicine.
The quality of evidence and grading of recommendations was appraised using the AGREE II tool.
|These updated guidelines have been commissioned by the Clinical Services and Standards Committee|
Dr Philip Newsome and colleagues examined guidelines that deal specifically with the management of abnormal liver blood tests in children and adults in both primary and secondary care under several subheadings.
The team investigated what constitutes an abnormal liver blood test.
The researchers also examined what constitutes a standard liver blood test panel.
The team evaluated when should liver blood tests be checked, and whether the extent and duration of abnormal liver blood tests determine subsequent investigation.
In addition, the team determined the response to abnormal liver blood tests.
Dr Newsome's team comments, "These updated guidelines on the management of abnormal liver blood tests have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gastroenterology (BSG) under the auspices of the liver section of the BSG.
"They are not designed to deal with the management of the underlying liver disease."